510(k) Report

510(k) · Cleared

Recalled · Class II · 2025

Giardia/Cryptosporidium Combo Rapid Assay

K983399510(k) TraditionalCleared Jan 11, 1999105-day reviewClass II21 CFR 866.3220Recalls 2

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Genzyme Diagnostics · MHI Giardia Spp.

Cleared on Jan 11, 1999 after a 105-day review. The FDA summary names its predicate without a number. 6 later devices descend from it. It has been recalled 2 times.

Decided
Jan 11, 1999
Review
105 days
Class
Class II
Product code
MHI
Recalls
2
Predicates
0

6 later devices descend from it, 3 citing it directly.

Descendants, by year cleared 2003: 3 descendants cleared2009: 1 descendant cleared2013: 2 descendants cleared1995200020052010201520202025
  1. This deviceK983399 Giardia/Cryptosporidium Combo Rapid AssayGenzyme Diagnostics · 1999
  2. Descendant · cites it directly · 2 of its ownK031942 Xpect Giardia Lateral Flow Assay, Model 2450020Remel, Inc. · 2003
  3. Descendant · cites it directly · 1 of its ownK031965 Xpect Cryptosporidium Lateral Flow Assay, Model 2451020Remel, Inc. · 2003 · Recalled
  4. Descendant · 2 generations on · 0 of its ownK120001 Unigold GiardiaTrinity Biotech · 2013
  5. Descendant · 2 generations on · 0 of its ownK121565 Uni-Gold CryptosporidiumTrinity Biotech · 2013
  6. Descendant · 2 generations on · 0 of its ownK081064 Giardia Fecal Antigen Detection Lateral Flow Kit, Model GL-LFIvd Research, Inc. · 2009

Showing 5 of 6 descendants. See all descendants

Descendants cleared per year

2003: 32009: 12013: 2
2003high 3 (2003) · low 0 (2004)2026

Most influential descendants

Showing 5 of 6 · See all
  • K031942Xpect Giardia Lateral Flow Assay, Model 2450020Remel, Inc. · 2003 · cites it directly2descendants
  • K031965Xpect Cryptosporidium Lateral Flow Assay, Model 2451020Remel, Inc. · 2003 · cites it directly1descendant
  • K120001Unigold GiardiaTrinity Biotech · 2013 · 2 generations on0descendants
  • K121565Uni-Gold CryptosporidiumTrinity Biotech · 2013 · 2 generations on0descendants
  • K081064Giardia Fecal Antigen Detection Lateral Flow Kit, Model GL-LFIvd Research, Inc. · 2009 · 2 generations on0descendants
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
0 (this device)K983399Giardia/Cryptosporidium Combo Rapid AssayGenzyme Diagnostics1999—
+1K031942Xpect Giardia Lateral Flow Assay, Model 2450020Remel, Inc.2003—
+1K031965Xpect Cryptosporidium Lateral Flow Assay, Model 2451020Remel, Inc.20031
+2K120001Unigold GiardiaTrinity Biotech2013—
+2K121565Uni-Gold CryptosporidiumTrinity Biotech2013—
+2K081064Giardia Fecal Antigen Detection Lateral Flow Kit, Model GL-LFIvd Research, Inc.2009—

Descendants by year cleared

Year clearedDevicesWith a Class I recall
200330
200910
201320
FIG. 1 — Lineage of K983399, 1999–2013Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in MHI? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

  • Candidate predicates for a device like this, rankedin the report
  • Recall history across each candidate’s familyin the report
Get a 510(k) Report

What was it cleared against? (1)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*—Alexon ProSpecT
Named without a submission number
—

What descends from it? (6)

3 later devices cite it directly; ranked here by how many devices descend from each in turn.

NumberDeviceApplicantDecidedDescendants
K031942Xpect Giardia Lateral Flow Assay, Model 2450020Remel, Inc.20032
K031965Xpect Cryptosporidium Lateral Flow Assay, Model 2451020Remel, Inc.20031
K031834Xpect Giardia/Cryptosporidium Lateral Flow AssayRemel, Inc.20030

Has anything in its family been recalled? (0 Class I)

Recalls of this device

DateClassRecallRoot causeReason
Mar 24, 2025Class IIZ-1719-2025Under Investigation by firmA single lot of the ImmunoCard STAT! Crypto/Giardia Test Kit was inadvertently stored in Medline warehouses at temperatures outside of the labeled storage requirements.
Feb 23, 2004Not classifiedZ-0770-04OtherFalse Positive results.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • Of its descendants, K031942 (Remel, Inc., 2003) has gone furthest, with 2 descendants of its own.

How does its category compare?

All MHI devices

MHI Giardia Spp.: FDA decisions, review times, recalls and adverse event reports over 20 years.

FDA decisions per year · MHI

1in 2013

2009: 12011: 12013: 1
2007high 1 (2009) · low 0 (2007)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · MHI

Too few MHI 510(k)s in any year since 2007 to give a median.

Recalls per year · MHI

1in 2025

2008: 12025: 1
2007high 1 (2008) · low 0 (2007)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · MHI

No MAUDE report names MHI since 2007.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20070—00
20080—10
20091—00
20100—00
20111—00
20120—00
20131—00
20140—00
20150—00
20160—00
20170—00
20180—00
20190—00
20200—00
20210—00
20220—00
20230—00
20240—00
20250—10
20260—0—

What is it indicated for?

This is an immunochromatographic assay for the simultaneous qualitative detection and distinguishing of Giardia and Cryptosporidium specific antigens in aqueous extracts of fecal specimens.

It is intended for professional laboratory use.

Indications for use read by OCR from a scanned FDA summary, so letters may be misread. Check the PDF before quoting it.

Cite this page

510(k) Report. “K983399: Giardia/Cryptosporidium Combo Rapid Assay.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 4, 2026. https://510kreport.com/device/K983399

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026